agilon health, inc. (AGL)
NYSE: AGL · Real-Time Price · USD
2.520
-0.180 (-6.67%)
At close: Oct 29, 2024, 4:00 PM
2.473
-0.047 (-1.88%)
After-hours: Oct 29, 2024, 7:58 PM EDT
agilon health Stock Forecast
Stock Price Forecast
The 14 analysts with 12-month price forecasts for agilon health stock have an average target of 7.14, with a low estimate of 3.00 and a high estimate of 18. The average target predicts an increase of 183.33% from the current stock price of 2.52.
Analyst Consensus: Hold
Analyst Ratings
The average analyst rating for agilon health stock from 16 stock analysts is "Hold". This means that analysts believe this stock is likely to perform similarly to the overall market.
Recommendation Trends
| Rating | May '24 | Jun '24 | Jul '24 | Aug '24 | Sep '24 | Oct '24 |
|---|---|---|---|---|---|---|
| Strong Buy | 1 | 1 | 1 | 1 | 1 | 1 |
| Buy | 3 | 3 | 3 | 3 | 3 | 3 |
| Hold | 10 | 10 | 10 | 10 | 10 | 10 |
| Sell | 1 | 1 | 1 | 1 | 1 | 2 |
| Strong Sell | 0 | 0 | 0 | 0 | 0 | 0 |
| Total | 15 | 15 | 15 | 15 | 15 | 16 |
Latest Forecasts
| Analyst | Firm | Rating | Rating | Action | Price Target | Upside | Date |
|---|---|---|---|---|---|---|---|
| Evercore ISI Group | Evercore ISI Group | Hold Maintains $7 → $4 | Hold | Maintains | $7 → $4 | +58.73% | Oct 8, 2024 |
| B of A Securities | B of A Securities | Strong Buy → Sell Downgrades $3 | Strong Buy → Sell | Downgrades | $3 | +19.05% | Oct 2, 2024 |
| Deutsche Bank | Deutsche Bank | Hold Maintains $5 → $4 | Hold | Maintains | $5 → $4 | +58.73% | Aug 9, 2024 |
| Benchmark | Benchmark | Strong Buy Reiterates $9 | Strong Buy | Reiterates | $9 | +257.14% | Aug 8, 2024 |
| RBC Capital | RBC Capital | Buy Reiterates $8 | Buy | Reiterates | $8 | +217.46% | Aug 7, 2024 |
Financial Forecast
Revenue This Year
6.08B
from 4.32B
Increased by 40.95%
Revenue Next Year
7.45B
from 6.08B
Increased by 22.45%
EPS This Year
-0.36
from -0.64
EPS Next Year
-0.17
from -0.36
Revenue Forecast
| Revenue | 2024 | 2025 | 2026 | 2027 | 2028 |
|---|---|---|---|---|---|
| High | 6.3B | 8.3B | 10.9B | ||
| Avg | 6.1B | 7.5B | 9.1B | ||
| Low | 5.9B | 6.9B | 7.7B |
Revenue Growth
| Revenue Growth | 2024 | 2025 | 2026 | 2027 | 2028 |
|---|---|---|---|---|---|
| High | 47.0% | 36.9% | 46.0% | ||
| Avg | 41.0% | 22.5% | 21.8% | ||
| Low | 36.3% | 13.2% | 4.0% |
EPS Forecast
| EPS | 2024 | 2025 | 2026 |
|---|---|---|---|
| High | -0.27 | 0.05 | 0.37 |
| Avg | -0.36 | -0.17 | -0.02 |
| Low | -0.39 | -0.30 | -0.16 |
EPS Growth
| EPS Growth | 2024 | 2025 | 2026 |
|---|---|---|---|
| High | - | - | - |
| Avg | - | - | - |
| Low | - | - | - |
Sources: Price targets and analyst ratings provided by Benzinga. Revenue and EPS forecast data provided by Finnhub. The data is sourced from Wall Street analysts. Data disclaimer.